simvastatin has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ceska, R; Fisar, Z; Kvasnicka, T; Papezová, H; Stárková, L; Vevera, J; Zdenek, H | 1 |
1 other study(ies) available for simvastatin and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission.
Topics: Adult; Anticholesteremic Agents; Blood Platelets; Cholesterol; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Female; Fluorescence Polarization; Humans; Hypercholesterolemia; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Serotonin Plasma Membrane Transport Proteins; Simvastatin; Time Factors | 2005 |